Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2025-12-24 @ 7:43 PM
NCT ID:
NCT02057003
Eligibility Criteria:
Inclusion Criteria:
* Older than 18 years
* HIV infection determined by enzymeimmunoassay and confirmed by Western Blot
* Naïve to treatment including a DAA
* Initiation of triple therapy including a DAA
* Written informed consent to participate in the study and to undergo genetic determinations
Exclusion Criteria:
* Pregnancy
* Any contraindication for the administration of peg-IFN, RBV or the respective DAA
* Patients who are not able to provide informed consent to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02057003
Study Brief:
Protocol Section:
NCT02057003